← Back to Search
Behavioural Intervention
Hula for Parkinson's Disease (PAHU Trial)
Honolulu, HI
N/A
Waitlist Available
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Primary diagnosis of idiopathic PD confirmed by a movement disorder specialist.
* Age over 25-years-old.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test the feasibility of a hula program for patients with Parkinson's disease. The hula program combines physical activity, social support, and stress reduction to potentially improve symptoms and quality of
See full description
Who is the study for?
This trial is for individuals over 25 years old with a primary diagnosis of idiopathic Parkinson's Disease, confirmed by a specialist. Participants should be at Hoehn and Yahr Stage 2.5 or below, meaning they can walk independently without balance issues, and must be able to give informed consent.Check my eligibility
What is being tested?
The PAHU study tests the feasibility of a hula program tailored for Parkinson's patients with mobility difficulties. It involves moderate physical activity designed to potentially prevent neurodegeneration, improve balance/mobility, reduce cardiovascular risks, provide social support, and enhance overall quality of life.See study design
What are the potential side effects?
Since this intervention involves physical activity in the form of hula dancing, potential side effects may include muscle soreness or strain. However, as it is non-pharmacological there are no medicinal side effects expected.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
* Primary diagnosis of idiopathic PD confirmed by a movement disorder specialist.
Select...
* Age over 25-years-old.
Select...
* Ability to give informed consent
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Retention
Secondary study objectives
PDQ-39
UPDRS-III
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Hula Pilot InterventionExperimental Treatment1 Intervention
Hula pilot 3 month program for PD patients.
Find a Location
Closest Location:The Queen's Medical Center· Honolulu, HI
Who is running the clinical trial?
University of HawaiiLead Sponsor
121 Previous Clinical Trials
55,176 Total Patients Enrolled